Clinical Application Observation on the Evaluation of Phantom Limb Pain With the Suralis System
1 other identifier
interventional
20
1 country
1
Brief Summary
This study tests whether a vibration-based feedback device (Suralis) can reduce phantom limb pain in people with lower-leg amputations over 3 weeks. Participants wear the device daily and report pain levels, walking ability, and quality of life - with no known risks, as it's a CE-certified medical device. If pain improves, the study team will help participants apply for insurance coverage to keep using the system long-term. The goal is to offer a simple, non-drug option that may help ease chronic pain and improve daily function for amputees. Participation is voluntary and can be stopped anytime without affecting medical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 23, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
January 7, 2026
December 1, 2025
1.3 years
December 23, 2025
December 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale (VAS)
Scores range from 0 to 100 mm, where 0 mm = "no phantom pain" and 100 mm = "worst imaginable phantom pain"; higher scores indicate greater pain intensity.
Baseline (t1), end of 3-week intervention (t3), and 3-week follow-up (t4) - assessed via daily VAS entries averaged per time point.
Secondary Outcomes (3)
German Pain Questionnaire DSF - subscales
Baseline (t1), end of 3-week intervention (t3), and 3-week follow-up (t4) - completed in person at study center.
Timed Up-and-Go (TUG) test
Baseline (t1), end of 3-week intervention (t3), and 3-week follow-up (t4) - performed once per visit at study center.
6-Minute Walk Test (6MWT)
Baseline (t1), end of 3-week intervention (t3), and 3-week follow-up (t4) - performed once per visit at study center; distance in meters recorded.
Study Arms (1)
Intervention with Suralis System
EXPERIMENTALAll participants receive a 3-week intervention with the Suralis vibrotactile feedback system, which provides real-time pressure-based sensory feedback via a sensorized insole and thigh-mounted vibrating cuff, calibrated individually via smartphone app to support pain reduction and gait stability.
Interventions
The Suralis system delivers real-time vibrotactile feedback via four pressure sensors embedded in a prosthetic insole, each mapped to a corresponding vibration motor on a thigh cuff. Participants wear the device during daily ambulation for 3 weeks. Vibration parameters (threshold, intensity, duration, spatial mapping) are individually calibrated via a smartphone app to match each user's sensory perception and gait pattern. The system operates autonomously, requires daily charging, and logs usage data via Bluetooth. No additional therapy or medication is administered alongside the device. The intervention aims to modulate cortical reorganization and reduce phantom limb pain while improving gait confidence and safety, particularly under non-visual conditions (e.g., stepping backward or sideways). The device is CE-marked (UDI: FBS 1 912012142) and classified as a Class IIa medical device under EU MDR 2017/746.
Eligibility Criteria
You may qualify if:
- Unilateral major lower-limb amputation (transtibial or transfemoral)
- Presence of persistent phantom limb pain, defined as daily pain intensity ≥ 3/10 on the Visual Analog Scale (VAS) during the baseline period
- Regular daily use of a prosthetic limb (minimum 4 hours/day)
- Adequate German language proficiency to understand and complete study questionnaires and follow study procedures
- Ability to provide informed consent
You may not qualify if:
- Unstable wound or skin condition at the residual limb
- Inconsistent prosthetic use (less than daily or \< 4 hours/day)
- Poorly fitting or non-functional prosthesis (as determined by study team)
- Incapacity to provide informed consent (e.g., due to cognitive impairment or severe psychiatric illness)
- Insufficient German language skills to comprehend study materials or complete assessments reliably
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medianlead
Study Sites (1)
MEDIAN Rehab Center Wiesbaden Sonnenberg
Wiesbaden, Hesse, 65191, Germany
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. med. Johannes Schroeter
Study Record Dates
First Submitted
December 23, 2025
First Posted
January 7, 2026
Study Start
April 1, 2025
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
January 7, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share